RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are...

Descripción completa

Detalles Bibliográficos
Autores principales: YILMAZ, Fatma, ALBAYRAK, Murat, ARAS, Merih REİS, MARAL, Senem, AFACAN ÖZTÜRK, Hacer Berna, TIĞLIOĞLU, Pınar, TIĞLIOĞLU, Mesut, SAĞLAM, Buğra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2021
Materias:
Pp 47
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572566/
http://dx.doi.org/10.1016/j.htct.2021.10.1057
Descripción
Sumario:One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects.

Ejemplares similares